Effect of pH on mutagenicity of urine from smokers and nonsmokers

Environmental Toxicology and Pharmacology

Volumn 13, Issue 1, 2003, Pages 21-27

  Mohamadi, Sarkar ^a   Unyime, Nseyo ^a   Bao Zhen, Zhong ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Bladder cancer; Cigarette smoke; Effect of pH; Smokers

Indexed keywords

ACETIC ACID DERIVATIVE; ACID; AROMATIC AMINE; BASE; GLUCURONIDE;

AMES TEST; ARTICLE; BLADDER CANCER; CARCINOGENESIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DRUG ACTIVATION; FEMALE; HUMAN; MALE; METABOLITE; MUTAGENESIS; MUTAGENIC ACTIVITY; MUTAGENICITY; PH; PRIORITY JOURNAL; RISK FACTOR; URINARY EXCRETION; URINE;

SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0037210425     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(02)00125-4     Document Type: Article

References (29)

1. American Cancer Society, 1999. Cancer Facts and Figure-1999. Cancer Facts and Figures.
2. Ames B.N., Maron D.M. Revised methods for the salmonella mutgenicity test. Mutat. Res. 113:1983;173-181.
3. Ames B.N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat. Res. 31:1975;347-364.
4. Badawi A.F., Hirvonen A., Bell D.A., Lang N.P., Kadlubar F.F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in human urinary bladder. Cancer Res. 55:1995;5230-5237.
5. Cartright R.A., Glashan R.W., Rogers H.J., Ahmad R.A., Barham-Hall D., Higgins E., Kahn M.A. Role of acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet. 2:1982;842-846.
6. Del Santo P., Moneti G., Salvadori M., Saltutti C., Delle Rose A., Dolara P. Levels of the adducts of 4-aminobiphenyl to hemoglobin in control subjects and bladder carcinoma patients. Cancer Letters. 60:1991;245-251.
7. Denissenko M.F., Pao A., Tang M., Pfeifer G.O. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in p53. Science. 274:1996;430-432.
8. Flammang T.J., Kadlubar F.F. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2′-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors and arylhydroxamic acid-dependent acyltransferases. Carcinogenesis. 7:1993;919-926.
9. Horn E.P., Tucker M.A., Lambert G., Silverman D., Sametkin D., Sinha R., Hatge T., Landi M.T., Caporaso N.E. A study of gender based cytochrome P450 1A2 variables: a possible mechanism for the male excess of bladder cancer. Cancer Epidemiol. Biomarkers Prev. 4:1995;529-533.
10. Irving C.C. Glucuronide formation in the metabolism of N-substituted aryl compounds. Natl. Cancer Inst. Mongr. 58:1981;109-111.
11. Josephy P.D., Chiu A.L., Eling T. Prostaglandin H synthase dependent mutagenic activation of benzidine in a salmonella typhimurium Ames tester strain possessing elevated N-acetyltransferase levels. Cancer Res. 49:1989;853-856.
12. Kadlubar F.F., Young J.F. A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption. Drug Metab. Disp. 10:1982;641-644.
13. Kadlubar F.F., Miller J.A., Miller E.C. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res. 37:1977;805-814.
14. Kadlubar F.F., Unruh L.E., Flammang T.J., Sparks D., Mitchum R.K., Mulder G.J. Alteration of urinary levels of the carcinogen, N-hydroxy-naphthylamine and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation and changes in biliary excretion. Chem. Biol. Interact. 33:1981;129-147.
15. Kadlubar F.F., Frederick C.B., Weiss C.C., Zenser T.V. Prostaglandin endoperoxide synthetase mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. Biochem. Biophys. Res. Comm. 108:1982;253-258.
16. Kadlubar F.F., Dooley K.L., Teitel C.H., Roberts D.W., Benson R.W., Butler M.A., Bailey J.R., Young J.F., Skipper P.W., Tannenbaum S.R. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. Cancer Res. 51:1991;4371-4377.
17. Kadlubar F.F., Butler M.A., Kaderlik K.R., Chou H.C., Lang N.P. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ. Health Perspect. 98:1992;69-74.
18. Kim J.H., Stansbury K.H., Walker N.J. Metabolism of benzo[a]pyrene-7,8-diol by human cytochrome P4501B1. Carcinogenesis. 19:1998;1847-1853.
19. Landi M.T., Zocchetti C., Bernucci I., Kadlubar F.F., Tannenbaum S., Skipper P., Bartsch H., Malaveille C., Shields P., Caporaso N.E., Vineis P. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol. Biomarkers Prev. 5:1996;693-698.
20. Radomski J.L., Brill E. Bladder cancer induction by aromatic amines: role of N-hydroxy. Metab. Sci. 16:1970;992-993.
21. Rothman N., Talaska G., Hayes R.B., Bhatnagaer V.K., Bell D.A., Lakshmi V.M., Kashyap S.K., Dosemeci M., Kashyap R., Hsu F.F., Jaeger M., Hirvonen A., Parikh D.J., Davis B.B., Zenser T.V. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol. Biomarkers Prev. 6:1997;1039-1042.
22. Sarkar M.A., Nseyo U.O., Zhong B.Z. Mutagenic outcome of the urinary carcinogen 4-aminobiphenyl is increased in acidic pH. Environ. Toxicol. Pharmacol. 11:2001;23-26.
23. Thompson I.M., Peek M., Rodriguez F.R. The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder. J. Urol. 137:1987;401-403.
24. Wada S., Yoshimura R., Masuda C., Hasae T., Ikemoto S., Kishimoto T., Fukushima S. Are tobacco use and urine pH indicated as risk factors for bladder carcinoma. Int. J. Urol. 8:2001;106-110.
25. Watanabe M., Nohmi T., Ishidate M. New murine strains of Salmonella typhimurium highly sensitive to mutagenic nitroarenes. Biochem. Biophys. Res. Comm. 143:1987;974-979.
26. Wolf H., Lower G.M., Bryan G.T. Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines. Scand. J. Urol. Nephrol. 14:1980;161-165.
27. Yamasaki E., Ames B.N. Concentration of mutagens from urine by adsorption with the nonpolar resin XAD-2. Proc. Natl. Acad. Sci. 74:1977;3555-3559.
28. Yu M.C., Ros R.K., Chan K.K., Henderson B.E., Skipper P.L., Tannenbaum S.R., Coetzee G.A. Acetylator phenotype aminobiphenyl hemoglobin adduct levels and bladder cancer risk in white, black and Asian men in Los Angeles. J. Natl. Cancer Inst. 86:1994;712-716.
29. Zenser T.V., Lakshmi V.M., Davis B.B. N-glucuronidation of benzidine and its metabolites. Role in bladder cancer. Drug Metab. Disp. 26:1998;856-859.